Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.
about
Lactobacillus GG in inducing and maintaining remission of Crohn's diseaseThe role of antibiotics and probiotics in pouchitisStructural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel diseaseBacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens.Antibiotics and probiotics in treatment of inflammatory bowel disease.Identification of a signalling molecule involved in bacterial intergeneric communication.Probiotics and prebiotics in chronic inflammatory bowel diseases.Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cellsBacterial probiotic modulation of dendritic cells.Pouchitis.Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.Mechanisms of action of probiotics: recent advances.The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.Streptococcus thermophilus ST28 ameliorates colitis in mice partially by suppression of inflammatory Th17 cells.Effects of Lactobacillus acidophilus dietary supplementation on the performance, intestinal barrier function, rectal microflora and serum immune function in weaned piglets challenged with Escherichia coli lipopolysaccharide.Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisPretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis.Probiotics and barrier function in colitis.Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitisRationale for probiotic treatment strategies in inflammatory bowel disease.Microbes, intestinal inflammation and probiotics.Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.The emerging therapeutic role of probiotics in inflammatory bowel disease.Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus.Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.The arginine-deiminase enzymatic system on gingivitis: preliminary pediatric study.Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model.Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.Stricture of ileo-anal J pouch anastomosis increased the intensity of pouchitis in an experimental rat model.Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis.Modulation of human dendritic cell phenotype and function by probiotic bacteria.Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.
P2860
Q24806098-E016031E-DCE5-4D14-BEC6-6E799440E98EQ27000314-E9686DCF-B458-4C37-9358-3A589A0682F2Q28821002-96056225-B0BA-46D2-9186-FBB6681C4D2EQ33231186-77C10BDF-EF8A-4F65-B33D-A662B898FCB0Q33290058-46299457-1AA9-404B-A441-78F531CD2231Q33867934-28C0E1AB-6712-415E-8BB8-7B92CA2E8AB3Q33913013-3B37B83F-B16B-425F-947D-7DFCA8B81A6BQ34013030-8212A7B7-7AC0-48BF-96B6-E3E1E0AC6445Q34013041-93BC0A56-7DB5-4898-93C6-EB8EEACB10DBQ34144168-6A0E4695-D5F7-487A-9B23-7610F07FE815Q34233134-A5D76957-0856-4FCA-9683-B467DB2DF4F3Q34637606-7005DCAB-1D39-428B-B9AE-47FE490ECDF4Q34796044-28A30A7C-423E-472C-AA6D-359B676EE36EQ34955775-0F8243CD-2894-47F1-B2E9-19C31C4F6147Q35059717-F98476AE-A38F-43B9-B473-CB40B49440D2Q35381281-B0916AF9-B035-48A8-A778-855610077171Q35541135-3BCE3683-C146-4477-89D3-FF619C3B41F8Q35596222-18469B54-B475-4046-8D79-39F6A619EE03Q35601294-8B0ACCE6-80D1-49FC-8028-BF7C7827E3F9Q35692273-966089EF-0083-48A4-B525-A03F1642A918Q36160698-0D8F24C1-E4A0-4FE3-9030-EB131B5EB86CQ36166985-EC23EE50-202D-456B-8B0A-16F08ECE73E6Q37345932-327066D2-934E-40D5-A1BF-F919BD1B75ADQ37965684-C72C9260-4A0C-4E55-8C72-6039E997F866Q38003046-5DD6C02E-BC49-48AF-A79C-59AE1D92B845Q38026552-93A2F3FB-743C-4C8B-898B-AA522911E4C0Q38442953-9363EDDC-3B1A-4791-B26E-9686E376C65BQ38935787-A95583D2-DA10-430B-A2F2-414A569BC93CQ39044374-6FBA5C5A-817B-4780-8B2D-3B15980F8FA4Q39179063-C83661B9-B64E-47B7-A934-BCAAFF1C61E2Q40266310-349A1862-8CAB-41D5-BDCF-5A93304094BEQ40604433-254BC3D4-8017-4CE4-ACF3-5AB7B6A37E37Q40685749-F125ACD2-3409-4DD4-A574-5B3DB516A569Q41587613-9431FB08-DA08-46C3-A200-CE4420C4C035Q42198986-3934A6DB-9793-44F4-A21A-F9E2F61C4149Q42580341-66CE84A1-E02F-4DC1-B68E-4D61049D593EQ43004747-A7F05A88-57A8-45F6-9CFB-6966A777E338Q43005855-2CA37900-B708-4F10-9433-5DEECC3B5801Q43162041-51557545-B0BC-4E26-975C-A2DFC70DFECBQ43460878-B57CA677-51CC-4ABB-B3F1-F23CDF3A9EF6
P2860
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Expression of cytokines, induc ...... ffects of probiotic treatment.
@en
Expression of cytokines, induc ...... ffects of probiotic treatment.
@nl
type
label
Expression of cytokines, induc ...... ffects of probiotic treatment.
@en
Expression of cytokines, induc ...... ffects of probiotic treatment.
@nl
prefLabel
Expression of cytokines, induc ...... ffects of probiotic treatment.
@en
Expression of cytokines, induc ...... ffects of probiotic treatment.
@nl
P2093
P2860
P1476
Expression of cytokines, induc ...... effects of probiotic treatment
@en
P2093
Campieri M
De Simone C
Gionchetti P
Rizzello F
P2860
P304
P356
10.1111/J.1572-0241.2001.04139.X
P407
P577
2001-09-01T00:00:00Z